Adacel®

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline, Dalhousie University

Conditions

Acellular PertussisDiphtheriaPertussisTetanus

Phase 3

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

CompletedNCT00346073

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus

Start: 2006-07-13End: 2007-03-07Updated: 2018-08-07

Phase 4

Adacel® Booster Vaccination for CMI Assay Development

CompletedNCT04543669

Dalhousie UniversityPertussis

Start: 2017-07-12End: 2017-09-20Updated: 2020-09-10